Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ether SCHEMBL254669 | 0.90 | TSHR (0.44) | LMNATSHRALDH1A1 | |
| Ether SCHEMBL5485860 | 0.90 | ALDH1A1 (0.43) | LMNATSHRALDH1A1 | |
| Ether SCHEMBL7738174 | 0.84 | LMNA (0.44) | LMNATSHRALDH1A1THRB | |
| Ether SCHEMBL28186488 | 0.80 | LMNA (0.41) | LMNAALDH1A1THRB | |
| Ether SCHEMBL20136143 | 0.80 | ALDH1A1 (0.42) | LMNATSHRALDH1A1THRB | |
| Ether SCHEMBL9750502 | 0.80 | — | — | |
| Butanol SCHEMBL7965789 | 0.79 | TSHR (0.67) | LMNATSHRALDH1A1THRB | |
| Ether SCHEMBL10662710 | 0.79 | LMNA (0.35) | LMNAALDH1A1THRB | |
| Ether SCHEMBL9762990 | 0.79 | LMNA (0.35) | LMNAALDH1A1THRB | |
| Ether SCHEMBL8160191 | 0.78 | ALDH1A1 (0.47) | LMNATSHRALDH1A1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111855864-A | Gas chromatographic analysis method of dimethyl cyclopropyl ether and neopentyl glycol | 青岛科技大学 | 2020-10-30 | — | — | CN | disclosed |
| CN-203479688-U | General gas detector | SHANGHAI EAGLE SAFETY EQUIPMENT LTD | 2014-03-12 | — | — | CN | disclosed |
| US-7534805-B2 | Imidazole derivatives, their preparation and their use as medicaments | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 2009-05-19 | — | — | US | disclosed |
| US-20070066542-A1 | Novel imidazole derivatives, their preparation and their use as medicaments | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATION SCIENTIFIQUES (S.C.R.A.S.) (FR) | 2007-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070066542-A1 | Novel imidazole derivatives, their preparation and their use as medicaments | MIF, MCL1, PPIP5K2 | LMNA 3647/4885TSHR 3264/4885ALDH1A1 988/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.